Cutaneous Plasmacytosis with Perineural Involvement

Importance. Cutaneous and systemic plasmacytosis are rare conditions of unknown etiology with characteristic red-brown skin lesions and a mature polyclonal plasma cell infiltrate within the dermis. Perineural plasma cell infiltrates may be a histologic clue to the diagnosis of cutaneous plasmacytosi...

Full description

Bibliographic Details
Main Authors: Elizabeth A. Brezinski, Maxwell A. Fung, Nasim Fazel
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:Case Reports in Dermatological Medicine
Online Access:http://dx.doi.org/10.1155/2014/840845
id doaj-432e724ad85442968247b6ecf4a3e6a2
record_format Article
spelling doaj-432e724ad85442968247b6ecf4a3e6a22020-11-24T22:49:13ZengHindawi LimitedCase Reports in Dermatological Medicine2090-64632090-64712014-01-01201410.1155/2014/840845840845Cutaneous Plasmacytosis with Perineural InvolvementElizabeth A. Brezinski0Maxwell A. Fung1Nasim Fazel2Department of Dermatology, Davis Health System, University of California, 3301 C Street, Suite 1400, Sacramento, CA 95816, USADepartment of Dermatology, Davis Health System, University of California, 3301 C Street, Suite 1400, Sacramento, CA 95816, USADepartment of Dermatology, Davis Health System, University of California, 3301 C Street, Suite 1400, Sacramento, CA 95816, USAImportance. Cutaneous and systemic plasmacytosis are rare conditions of unknown etiology with characteristic red-brown skin lesions and a mature polyclonal plasma cell infiltrate within the dermis. Perineural plasma cell infiltrates may be a histologic clue to the diagnosis of cutaneous plasmacytosis. Observations. Our patient had a five-year history of persistent reddish-brown plaques on the neck and trunk without systemic symptoms. Histologic examination showed dermal perivascular and perineural plasma cells with excess lambda light chain expression. Due to decreased quality of life caused by his skin lesions, he was placed on a chemotherapeutic regimen with bortezomib. Conclusions and Relevance. The patient was diagnosed with cutaneous plasmacytosis based on classic histopathology results with a recently characterized pattern of perineural involvement. Bortezomib therapy was initiated to manage his skin eruption, which has not been previously described as a treatment for this chronic condition.http://dx.doi.org/10.1155/2014/840845
collection DOAJ
language English
format Article
sources DOAJ
author Elizabeth A. Brezinski
Maxwell A. Fung
Nasim Fazel
spellingShingle Elizabeth A. Brezinski
Maxwell A. Fung
Nasim Fazel
Cutaneous Plasmacytosis with Perineural Involvement
Case Reports in Dermatological Medicine
author_facet Elizabeth A. Brezinski
Maxwell A. Fung
Nasim Fazel
author_sort Elizabeth A. Brezinski
title Cutaneous Plasmacytosis with Perineural Involvement
title_short Cutaneous Plasmacytosis with Perineural Involvement
title_full Cutaneous Plasmacytosis with Perineural Involvement
title_fullStr Cutaneous Plasmacytosis with Perineural Involvement
title_full_unstemmed Cutaneous Plasmacytosis with Perineural Involvement
title_sort cutaneous plasmacytosis with perineural involvement
publisher Hindawi Limited
series Case Reports in Dermatological Medicine
issn 2090-6463
2090-6471
publishDate 2014-01-01
description Importance. Cutaneous and systemic plasmacytosis are rare conditions of unknown etiology with characteristic red-brown skin lesions and a mature polyclonal plasma cell infiltrate within the dermis. Perineural plasma cell infiltrates may be a histologic clue to the diagnosis of cutaneous plasmacytosis. Observations. Our patient had a five-year history of persistent reddish-brown plaques on the neck and trunk without systemic symptoms. Histologic examination showed dermal perivascular and perineural plasma cells with excess lambda light chain expression. Due to decreased quality of life caused by his skin lesions, he was placed on a chemotherapeutic regimen with bortezomib. Conclusions and Relevance. The patient was diagnosed with cutaneous plasmacytosis based on classic histopathology results with a recently characterized pattern of perineural involvement. Bortezomib therapy was initiated to manage his skin eruption, which has not been previously described as a treatment for this chronic condition.
url http://dx.doi.org/10.1155/2014/840845
work_keys_str_mv AT elizabethabrezinski cutaneousplasmacytosiswithperineuralinvolvement
AT maxwellafung cutaneousplasmacytosiswithperineuralinvolvement
AT nasimfazel cutaneousplasmacytosiswithperineuralinvolvement
_version_ 1725676753092870144